Statistics for CD320 as a potential clinical biomarker for GOF p53 mutants in non-small cell lung cancer
Total visits
| views | |
|---|---|
| CD320 as a potential clinical biomarker for GOF p53 mutants in non-small cell lung cancer | 10 |
Total visits per month
| views | |
|---|---|
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 3 |
| September 2024 | 1 |
| October 2024 | 2 |
| November 2024 | 4 |
| December 2024 | 0 |
Top country views
| views | |
|---|---|
| Kazakhstan | 4 |